May 25, 2021 / 01:00PM GMT
Matthew Charles Taylor - UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Good morning, everyone, and welcome to our next session here at the UBS global health care conference.
I'm Matt Taylor, and I'm the U.S. medical supplies and devices analyst hosting sessions here in the medtech track and really excited to have with us management from Boston Scientific.
So we've got a number of leaders here from the peripheral and oncology group, including Jeff Mirviss, EVP and Global President of Peripheral Interventions, President of Interventional Oncology; Cat Jennings, who's VP of Vascular Marketing, New Business Development, and GM for Varithena; and also have Susie Lisa, the VP of Investor Relations and (inaudible) as well. So we're going to focus on peripheral and oncology, but we can ask Susie and Lauren some questions about broader BSC. Or they'll keep me in line if we're trying to get these folks off track and give us all the secrets, but I just want to start by saying thanks a lot for joining us today and really appreciate you taking the
Boston Scientific Corp at UBS Global Healthcare Virtual Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers